Financial Performance - For the six months ended September 30, 2021, the group's revenue was approximately HKD 111.2 million, a significant increase from HKD 35.3 million for the same period in 2020, representing a growth of 215%[17]. - The group reported a net profit of approximately HKD 9.8 million for the six months ended September 30, 2021, compared to a net loss of HKD 14.4 million for the same period in 2020, marking a turnaround in performance[17]. - The company reported a net profit of HKD 9,770,000 for the six months ended September 30, 2021, compared to a net loss of HKD 14,385,000 for the same period in 2020, indicating a significant turnaround[25]. - Revenue from treatment services reached HKD 108,497,000 for the six months ended September 30, 2021, a substantial increase from HKD 33,811,000 in the previous year, reflecting a growth of approximately 220%[36]. - The net cash generated from operating activities was HKD 14,679,000, compared to HKD 4,609,000 in the prior year, showing an increase of about 218%[27]. - The company recorded a total comprehensive income of HKD 21,680,000 as of September 30, 2021, up from HKD 24,484,000 in the previous year[25]. - The company’s total revenue for the six months ended September 30, 2021, was HKD 111,192,000, compared to HKD 35,262,000 in the previous year, marking an increase of approximately 215%[36]. - The increase in revenue was primarily due to the absence of COVID-19 related closures that affected the medical beauty centers in the same period of 2020 and the revenue generated from new centers opened in May 2021[68]. Dividends and Shareholder Returns - The board of directors did not recommend the distribution of dividends for the six months ended September 30, 2021, consistent with the previous year where no dividends were declared[17]. - The company did not declare any dividends for the six months ended September 30, 2021, consistent with the same period in 2020[47]. - The company did not recommend any interim dividend for the six months ended September 30, 2021, consistent with the previous year[85]. Assets and Liabilities - Total assets less current liabilities amounted to HKD 88.988 million as of September 30, 2021, slightly down from HKD 90.367 million as of March 31, 2021[21]. - Non-current assets increased to HKD 175.003 million as of September 30, 2021, compared to HKD 176.821 million as of March 31, 2021[21]. - The group’s total liabilities were HKD 156.815 million as of September 30, 2021, compared to HKD 156.570 million as of March 31, 2021, indicating stable liability management[23]. - The company has a net current liability of HKD 86,015,000, primarily due to contract liabilities of HKD 107,382,000, which are expected to generate cash inflows without leading to cash outflows[30]. - As of September 30, 2021, the company's total equity was approximately HKD 21.7 million, up from approximately HKD 11.9 million as of March 31, 2021[81]. - The company reported unsecured and secured bank borrowings of approximately HKD 15.0 million as of September 30, 2021, down from approximately HKD 17.6 million on March 31, 2021[99]. - The company had cash and bank balances of approximately HKD 29.9 million as of September 30, 2021, down from approximately HKD 39.4 million as of March 31, 2021[81]. - The company’s debt-to-equity ratio was 464.0%, a significant decrease from 940.1% on March 31, 2021[94]. Employee Costs and Investments - The group’s employee costs rose to HKD 35.902 million for the six months ended September 30, 2021, compared to HKD 18.433 million for the same period in 2020, indicating increased workforce investment[19]. - Total employee costs increased to HKD 35,902,000 for the six months ended September 30, 2021, from HKD 18,433,000 in the previous year, representing an increase of approximately 95%[40]. - The average salary for key management personnel increased to HKD 3,071,000 for the six months ended September 30, 2021, from HKD 2,093,000 for the same period in 2020[61]. - Capital expenditure for the six months ended September 30, 2021, was approximately HKD 15.9 million, which included the purchase of treatment equipment and renovations, compared to HKD 3.4 million in the same period in 2020[84]. - The group purchased property, plant, and equipment totaling approximately HKD 15,884,000 for the six months ended September 30, 2021, compared to HKD 3,356,000 for the same period in 2020[51]. Market and Operational Strategy - The company plans to open a new center in Tsim Sha Tsui by the end of 2021 to expand its operational scale and enhance profitability[64]. - The company aims to increase its service offerings to enhance its competitive advantage as it expands its network of medical beauty centers[64]. - The company plans to closely monitor market conditions and strengthen its sustainable development strategies to overcome current adversities while maximizing shareholder value[67]. - The company continues to monitor regulatory changes in the medical beauty service sector, which may impact operational costs and profit margins[90]. Governance and Compliance - The company has maintained compliance with corporate governance codes and has established an audit committee to oversee financial reporting[105]. - The company has not purchased, sold, or redeemed any of its listed securities during the reporting period[107]. - No directors or their associates engaged in any business that directly or indirectly competes with the group during the reporting period[119]. Miscellaneous - The company did not receive any government subsidies during the current period, contrasting with HKD 6,512,000 received in the same period last year[38]. - Other income decreased to approximately HKD 0.3 million from HKD 7.5 million in the previous year, mainly due to the absence of government subsidies under the anti-epidemic fund during the period[71]. - The deferred tax expense for the period was HKD 186,000, compared to HKD 40,000 in the previous year, indicating an increase in tax obligations[41]. - There were no significant contingent liabilities as of September 30, 2021, compared to zero on March 31, 2021[97]. - The company has not experienced any significant impact from foreign exchange fluctuations, as most transactions are conducted in HKD[96]. - The company has no major plans for significant investments or capital assets as of September 30, 2021[92]. - The stock option plan was adopted to attract, retain, and reward eligible individuals for their contributions to the group, effective for ten years unless terminated by a resolution at a shareholders' meeting[115][116]. - No stock options, warrants, or convertible securities have been granted, exercised, or cancelled since the adoption of the stock option plan[116].
亮晴控股(08603) - 2022 - 中期财报